{
  "docId": "019de073-a7b5-7720-904b-d55cb9d2acd2",
  "docSlug": "ff09795c4205ae982e453519f0f2447b",
  "documentTitle": "Bionomics | Investor Presentation Deck | 59 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 47,
  "pageCount": 59,
  "prevPage": 46,
  "nextPage": 48,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a bar chart to compare placebo vs BNC210 across two metrics: total number of symptoms and symptom intensity.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a7b5-7720-904b-d55cb9d2acd2/47",
  "deckHref": "/decks/019de073-a7b5-7720-904b-d55cb9d2acd2",
  "deckJsonHref": "/decks/019de073-a7b5-7720-904b-d55cb9d2acd2.json",
  "deckAnchorHref": "/decks/019de073-a7b5-7720-904b-d55cb9d2acd2#slide-47",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.55,
        "x": 0.42,
        "y": 0.18
      },
      "kind": "chart",
      "text": "BNC210 demonstrated reduction in panic symptoms as measured with the Panic Symptom Scale",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b359774d-d154-4b1c-9f44-5d41c4b7c40b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.35,
        "x": 0.04,
        "y": 0.45
      },
      "kind": "list",
      "text": "Subjects assessed after a single dose of BNC210 as they would be in an acute SAD trial setting\nProof of Principle in demonstrating anxiolytic activity",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cee3bd2a-1cc9-4ad4-9003-bd8a210ace1a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Phase 1b placebo-controlled study evaluating BNC210 in acute anxiety in 15 healthy volunteers who experienced a CCK-4-induced panic attack",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21e2977d-8e58-4e03-908f-403c9a9cf136",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.08,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "CCK-4 = Cholecystokinin Tetrapeptide (a peptide that induces anxiety and panic symptoms)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df261469-4d30-42e3-a0ae-aa8f2bc70e2d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "BNC210 Reduces Anxiety and Panic Symptoms in Humans",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa2d74f8-1f63-480f-922d-6ae94ff00a85",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}